Type 2 Diabetes Mellitus Completed Phase 3 Trials for Glimepiride (DB00222)

Also known as: Diabetes Mellitus Non-insulin-dependent / Type-2 Diabetes Mellitus / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus Type-2 / Type 2 Diabetes (T2DM) / Diabetes, Type 2 / Diabetes Mellitus, Type 2 (T2DM) / Diabetes Mellitus,Type 2 / Diabetes Type II / Type-II Diabetes Mellitus / Diabetes Mellitus 2 Type / T2DM / Diabetes Mellitus Type II / Type II Diabetes / Diabetes Mellitus, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Diabetes Type Two / Diabetes Mellitus - Type 2 / Diabetes, Type II / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus. Type 2 / Diabetes Type 2 / Type 2 Diabetes Mellitus (T2D) / Type 2 Diabetes (T2D) / Type II; Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / NIDDM / Type-2 Diabetes / Type 2 Diabetes Mellitus(T2DM) / Type 2 Diabetes / Type 2-diabetes / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Mellitus Type 2 / Type Two Diabetes Mellitus / T2DM (Type 2 Diabetes Mellitus) / Type-2-diabetes Mellitus / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01841697Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)Treatment
NCT00680745Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes PatientsTreatment
NCT03332771Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Subjects With Type 2 Diabetes Mellitus That Are Taking Metformin MonotherapyTreatment
NCT02769481Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsTreatment
NCT01644500A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes MellitusTreatment
NCT01242215A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic PatientsTreatment
NCT02630706A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)Treatment
NCT01177384Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)Treatment
NCT01590771A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)Treatment
NCT01682759A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)Treatment
NCT01717313A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)Treatment
NCT01704261Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)Treatment
NCT01755156A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)Treatment
NCT02036515Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)Treatment
NCT02099110Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)Treatment
NCT02226003Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)Treatment
NCT01958671A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)Treatment
NCT01233622Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus GlimepirideTreatment
NCT00032487Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)Treatment
NCT00131664Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)Treatment
NCT00353691Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes MellitusTreatment
NCT00359762Exenatide Versus Glimepiride in Patients With Type 2 DiabetesTreatment
NCT00924573Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of GlimepirideTreatment
NCT00974090Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 DiabetesTreatment
NCT01076075A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)Treatment
NCT01189890Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)Treatment
NCT01340768Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)Treatment
NCT01457911Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With MetforminTreatment
NCT01494987Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes MellitusTreatment
NCT01699932Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately ControlledTreatment
NCT01769378Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)Treatment
NCT01243424CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesTreatment
NCT01495013A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes MellitusTreatment
NCT00437554Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)Treatment
NCT00968812CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus GlimepirideTreatment
NCT00740051A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is InappropriateTreatment
NCT01087502Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal ImpairmentTreatment
NCT00622284Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 DiabetesTreatment
NCT01296412Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)Treatment
NCT00783744Insulin Glargine Combination Therapies in Type II DiabeticsTreatment
NCT00614120Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 DiabetesTreatment
NCT01459809Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes PatientsTreatment
NCT00620282The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes MellitusTreatment
NCT00000620Action to Control Cardiovascular Risk in Diabetes (ACCORD)Prevention
NCT00838903Efficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesTreatment
NCT00839527A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesTreatment
NCT00318461To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherTreatment
NCT00318422Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesTreatment
NCT00331851Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesTreatment
NCT00099944Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesTreatment
NCT01075282A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)Treatment
NCT00106340Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 DiabetesTreatment
NCT01167881Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 DiabetesTreatment
NCT01262586Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.Treatment
NCT00151697LANN-study: Lantus, Amaryl, Novorapid, Novomix StudyTreatment